0001815337-20-000001.txt : 20200706 0001815337-20-000001.hdr.sgml : 20200706 20200706171057 ACCESSION NUMBER: 0001815337-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200706 DATE AS OF CHANGE: 20200706 EFFECTIVENESS DATE: 20200706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Santi Therapeutics, Inc. CENTRAL INDEX KEY: 0001815337 IRS NUMBER: 843078067 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-370304 FILM NUMBER: 201014230 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR STREET 2: C/O RA CAPITAL CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2572 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR STREET 2: C/O RA CAPITAL CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001815337 Santi Therapeutics, Inc. 200 BERKELEY STREET, 18TH FLOOR C/O RA CAPITAL BOSTON MA MASSACHUSETTS 02116 617-778-2572 DELAWARE None None Corporation true 2019 Milind Deshpande 200 Berkeley Street, 18th Floor c/o RA Capital Boston MA MASSACHUSETTS 02116 Executive Officer Director Andrew Levin 200 Berkeley Street, 18th Floor c/o RA Capital Boston MA MASSACHUSETTS 02116 Director Joshua Resnick 200 Berkeley Street, 18th Floor c/o RA Capital Boston MA MASSACHUSETTS 02116 Director Nathaniel Brooks Horwitz 200 Berkeley Street, 18th Floor c/o RA Capital Boston MA MASSACHUSETTS 02116 Director Pharmaceuticals Decline to Disclose 06b false 2020-05-22 true true false 0 14000000 6000000 8000000 false 3 0 0 0 false Santi Therapeutics, Inc. Milind Deshpande Milind Deshpande President 2020-07-06